Back to Search
BRADLEY EMMERICH, MD
MD
Emergency Medicine Physician
NPI: 1801475447IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
4351047937(MI)78053(MN)MD-53766(IA)83274-20(WI)
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 2021
Research & Publications (20)
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
PMID 19605849·Blood·2009
3-trial
Helper T cells (CD3 + /CD4 + ) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients.
PMID 18806749·Exp Oncol·2008
8-other
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
PMID 17665197·Cancer Immunol Immunother·2008
7-preclinical
Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways.
PMID 17653574·J Cancer Res Clin Oncol·2008
8-other
Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cells.
PMID 17351392·Anticancer Drugs·2007
8-other
AML M1 presenting with recurrent acute large arterial vessel thromboembolism.
PMID 17011031·Leuk Res·2007
5-case
Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
PMID 17083342·Br J Haematol·2007
3-trial
Inhibition of lymphocyte function associated antigen 1 by LFA878 induces apoptosis in multiple myeloma cells and is associated with downregulation of the focal adhesion kinase/phosphatidylinositol 3 kinase/Akt pathway.
PMID 17786331·Int J Oncol·2007
8-other
Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
PMID 17669398·Exp Cell Res·2007
8-other
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
PMID 17340589·Cancer·2007
3-trial
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells.
PMID 17495978·Leukemia·2007
7-preclinical
First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma.
PMID 17655704·Eur J Haematol·2007
3-trial
Synergistic antimyeloma effects of zoledronate and simvastatin.
PMID 16917207·Anticancer Drugs·2006
8-other
Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation.
PMID 17050252·Cytotherapy·2006
3-trial
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
PMID 16219797·Blood·2006
4-observational
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
PMID 16611304·Br J Haematol·2006
7-preclinical
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
PMID 15746051·Clin Cancer Res·2005
4-observational
Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.
PMID 16219572·Haematologica·2005
3-trial
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
PMID 15071604·Leukemia·2004
3-trial
Chronic lymphocytic leukaemia: up-dated recommendations on diagnosis and treatment.
PMID 15007256·Onkologie·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1900 SOUTH AVE
LA CROSSE, WI 54601 - Phone
- (608) 782-7300
Quick Facts
- NPI
- 1801475447
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile